Support Childhood Cancer Canada by getting outside and enjoying winter | Breakaway Winter Adventure January 25 to March 29, 2021 | Earn and share fun badges | Invite friends and coworkers
Following the success of the Childhood Cancer Canada summer virtual event (Breakaway Cycling Adventure 2020 raised over $72,000 with 96 participants), Breakaway Winter Adventure is a solo badge challenge that raises funds for important research and provides vital programming and support for families dealing with childhood cancer.
Breakaway Winter Adventure was built to include all participation levels. Choose your own adventure through the badges you collect!
Let’s have fun this winter and most importantly, let’s have fun with purpose!
3 categories (Challenge / Fun / Family)
9 challenges in each category
27 possible badges to achieve
How BREAKAWAY Winter Adventure works
- Register and get ready for fun starting on January 25, 2021. https://www.childhoodcancer.ca/Events/Breakaway
- Earn badges when you complete challenges. Pick challenges that match your participation level – Challenge Road / Fun Lane / Family Avenue (or do all of them!)
- Invite friends and family to join you.
- Fundraise online for childhood cancer research and Foundation programming.
- Join our Strava Club.
- Post your fun on your socials and tag @childhoodcancercanada and #breakawaykidscancer
See the press release at: https://www.childhoodcancer.ca/About-Us/News/Breakaway-Winter-Adventure-2021
POGO AfterCare Education Day is going virtual!
We invite those near and far to take part in what promises to be an interactive and engaging program focused on the care and unique needs of childhood cancer survivors. This multidisciplinary education day is for anyone involved in caring for this important patient population.
Join us on Friday, May 14 to learn, connect and engage with others in the childhood cancer community. Stay tuned for program updates and registration information, coming soon on the POGO website.
While the primary audience is interdisciplinary AfterCare health professionals who work with survivors, the program is certainly relevant to all who diagnose, treat and monitor children with cancer.
Registration and program details will be released shortly. Please check back for more information, and follow @POGO4kids on Twitter and @PediatricOncologyGroupofOntario on Facebook for ongoing updates!
JOB POSTING: Clinical Research Associate (CRA) for the Michael Cuccione Childhood Cancer Research Program (MC3RP) at BC Children’s Hospital – apply by Feb 2/21
Full job posting and application instructions at: https://ubc.wd10.myworkdayjobs.com/ubcstaffjobs/job/UBC-Off-Campus-Hospital-Sites/Clinical-Research-Associate–Hem-Onc-BMT-_JR881
Applications will be accepted until the end of 02-Feb-2021
This position is responsible for coordinating clinical research protocols conducted by the Michael Cuccione Childhood Cancer Research Program (MC3RP) within the Children’s and Women’s Health Centre of BC’s Division of Hematology/Oncology/Bone Marrow Transplant (Hem/Onc/BMT) and the BC Children’s Hospital Research Institute. The MC3RP supports around 100 active clinical research studies for children in British Columbia with cancer and blood disorders. These studies include, but are not limited to, research on active treatment, supportive care, and the long-term effects of cancer and blood disorders therapy. The MC3RP has a number of research affiliations that include the Children’s Oncology Group, Industry Sponsors, the C17 Childhood Cancers and Blood Disorders, National Cancer Institute of Canada (NCIC), Precision Oncology For Young people (PROFYLE), Canadian Cancer Trials Group (CCTG), Pediatric Blood and Marrow Transplant Consortium (PBMTC), Pediatric Cancer Immunotherapy Trials Network (PedCITN), Centre for International Blood and Marrow Transplant Research (CIBMTR), Canadian Bone Marrow Transplantation Group (CBMTG) as well as investigator-initiated research.
The incumbent is required to conduct all research activities in an ethical manner, suited to the proper activities of the University of British Columbia and to the professional organizations governing his or herself and those governing the activities of the institution and all other investigators. Any procedures or data recorded as part of a trial must be accurate and must accurately reflect the work performed. Strict confidentiality of all study participants must be adhered to. All activities involving participants are accountable to the Principal Investigator, the Division Head of Hematology/Oncology/Bone Marrow Transplant, and the candidate’s governing professional organization.
To coordinate clinical research protocols, including but not limited to Phases I, II and III chemotherapy studies, hematology studies, bone marrow transplant studies, supportive care studies and ancillary studies::
- Ensuring adherence to and maintenance of protocols
- Maintaining protocols and associated documents to ensure they are up-to date
- Responsible for the day-to-day operation of multi-site investigator initiated project
- Working closely with the clinical research staff
- Identifying potential study participants
- Reviewing and confirming eligibility criteria
- Registration of patients on clinical studies
- Creation of study specific documents
- Accurate and timely completion and submission of paper and electronic data capture forms
- Creating and maintaining research charts on registered subjects
- Reporting adverse drug reactions in consultation with physician and in accordance with protocol-specific guidelines
- Procuring and safely shipping as well as maintaining accurate documentation of study specimens from
various sources according to protocol guidelines and federal regulations
- Acting as liaison with health care team and laboratory team, both on-site and outside the institution, for
project management and information exchange regarding clinical studies
- Performing data entry and managing research databases with accuracy
- Preparing and participating in audits and study monitoring visits from various regulatory bodies
- Attending conferences and meetings, possibly involving travel
- Timely completion of required regulatory certificates and tutorials
- Maintaining clinical research education and regulatory certifications
- Providing back-up for other team members while sick or on holidays
- If not already obtained, the division will support training for clinical research professional certification
through the Society of Clinical Research Associates
- Performing other related tasks and projects as deemed necessary
Undergraduate degree in a relevant discipline or Graduation from a technical college or institute. Clinical research professional certification through the Society of Clinical Research Associates (SoCRA) or the Association of Clinical Research Professionals (ACRP), transportation of Dangerous Goods Certificate preferred. Minimum of 3 years related experience or the equivalent combination of education and experience. Required: Knowledge of medical terminology and patient record systems.
Assets: Demonstrated knowledge and experience with Pediatric oncology, familiarity with database management programs. Knowledge of Good Clinical Practice. Attentive to detail, with the ability to work quickly and accurately. Medium to high degree of computer literacy including familiarity with Microsoft Word, Access and Excel. Excellent organizational and interpersonal skills a must. Ability to prioritize and work effectively under pressure to meet deadlines. Ability to exercise initiative and maintain confidentiality. Communicates effectively both orally and in writing. Ability to learn new software. Ability to work both independently and within a team environment. Physical ability to do the job.
MICYRN and CHEER are hosting several webinars at the end of January for the child health and clinical trial community. Please visit http://www.micyrn.ca/webinars for details and to register. Space is limited.
Engaging Youth and Parents as Partners in Clinical Research
- January 18, 8:00-9:00 am (PST)
- Katie Birnie (SKIP), Dawn Richards (CTO), Vivian Tsang (YPAG Kidscan)
From Trials to Treatments: Why the Selection, Measurement, and Reporting of Outcomes Is Key in Pediatric Clinical Research (Star Child Seminar)
- January 19, 10:00-11:00 am (PST)
- Nancy Butcher (SickKids)
De-mystifying Privacy: Research Uses of Administrative Data
- January 20, 10:00-11:30 am (PST)
- Holly Longstaff (PHSA), Donna Curtis Maillet (New Brunswick Institute for Research Data and Training), Charles Burchill (University of Manitoba)
Risk-based Approach for Pediatric Clinical Trials
January 21, 10:00-11:30 am (PST)
- Carole Legare and Daniel Keene (Health Canada)
Request for Applications: National Pediatric Oncology REB Coordinator. Applications due by 29-Jan-2021
As part of our renewed participation in 3CTN, the C17 Council is calling for applications for a 0.5 FTE National REB Coordinator starting immediately for a period of approximately 18 months, pending 3CTN funding renewal.
The successful application can be based at any of the C17 3CTN Network Affiliated Cancer Centres (NACCs), although familiarity with either the Quebec centralized review process or OCREB would be an asset.
The full RFA can be downloaded below and from C17.ca
Your application from your institution should include the following:
- Vision for the role and proposed work plan (max 2 pages)
- Support of local Director and COG PI
- Acknowledgment of oversight/involvement of the local institutional Research Manager
- CV of proposed National REB Coordinator applicant
- Against Pandemic Research Exceptionalism with Dr. Jonathan Kimmelman on July 7, 2020
- Monitoring Investigator Initiated Trials IITS During the COVID Pandemic – A Dialogue with Lisa Johnston on August 26, 2020
- Clinical Trials Education & Awareness Tools in Action: Talking Through How to Access and Find Them with Shelley King, Daniela Bianco, Alison Orth and Catherine Vayssier on November 5, 2020
REGISTER today & work on your for the APRIL 8, 2021 ADOLESCENT AND YOUNG ADULT ONCOLOGY VIRTUAL SYMPOSIUM | Abstracts due Feb 1
Registration and more information: https://www.eventbrite.ca/e/caring-for-the-future-adolescent-and-young-adult-symposium-registration-127076730923
Sponsored by the Michael Kamin Hart Fund (AYA Program at Princess Margaret Cancer Center) this symposium will aim to highlight new advances in AYA oncology from both researchers and community partners.
Target audience: health care providers, trainees, researchers
All welcome: patients, community organizations, advocacy groups, government, hospital administration
DRAFT THEMES/LEARNING OBJECTIVES:
1. Innovation in AYA Oncology: harms and benefits of cannabis, complimentary therapies, other treatments
2. Teach the Doctor: teach physicians how to talk to patients about advanced cancer/palliation, recognize mental health issues in patients, teach key skills/tools to improve care delivery
3. General Care/survivorship/palliation: improving all aspects of the cancer journey
We invite all [researchers, community partners] to submit abstracts related to their completed or planned research, program development and/or new initiatives in AYA oncology. Abstracts will be reviewed by a scientific committee and only the highest quality abstracts will be selected for 8 minute ORAL PRESENTATIONS. [there will be no posters]
Abstract DEADLINE: February 1, 2021
Abstract NOTIFCATION: March 1, 2021
For more information, contact us: email@example.com
Our plenary speaker is Dr. Ursula Sansom-Daly. https://www.behaviouralsciencesunit.org/dr-ursula-sansom-daly.html
There will 2 keynote speakers:
1. Dr. Rachel Taylor: http://www.brightlightstudy.com/about/faith-gibson/
2.Dr. Emily Drake: http://www.emilydrake.ca/
Opportunities and Challenges in Drug Development for Pediatric Cancers. Theodore W. Laetsch, Steven G. DuBois, Julia Glade Bender, Margaret E. Macy and Lucas Moreno. Cancer DiscovERY
December 4 2020 DOI: 10.1158/2159-8290.CD-20-0779
PAPER OF INTEREST: Managing teamwork in the face of pandemic: evidence-based tips (BMJ Quality and Safety, free access)
Tannenbaum SI, Traylor AM, Thomas EJ, et al. Managing teamwork in the face of pandemic: evidence-based tips. BMJ Quality & Safety 2021;30:59-63.